Who Owns Immunic Stock?
NASDAQ: IMUXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 71.18%
- Held by insiders
- 0.97%
- Institutional holders
- 67
- Institutions 71.2%
- Insiders 1.0%
- Public and other 27.9%
Who owns Immunic stock?
Institutional investors own about 71.2% of Immunic's shares, spread across 67 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.97% of IMUX.
The largest institutional holders are Aberdeen Group plc (6.04%), BVF Inc. (5.61%) and Millennium Management Llc (5.43%). Together, the top 10 institutions control 46.1% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their IMUX positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of IMUX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Aberdeen Group plc | 824.39K | 6.04% | 0.0% |
| BVF Inc. | 765.29K | 5.61% | 0.0% |
| Millennium Management Llc | 740.35K | 5.43% | +95.9% |
| Avidity Partners Management, LP | 669.94K | 4.91% | 0.0% |
| Braidwell LP | 645.01K | 4.73% | +100.0% |
| Laurion Capital Management, LP | 610.33K | 4.47% | +57.2% |
| Vanguard Capital Management LLC | 571.56K | 4.19% | +11.2% |
| Jones Hill Capital LP | 539.81K | 3.96% | +100.0% |
| Woodline Partners LP | 471.53K | 3.46% | +387.5% |
| Soleus Capital Management, L.P. | 450.00K | 3.30% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of IMUX
| Fund | Shares | % Held |
|---|---|---|
| abrdn Healthcare Investors | 473.88K | 3.47% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 399.09K | 2.92% |
| abrdn Life Sciences Investors | 302.89K | 2.22% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 159.25K | 1.17% |
| abrdn World Healthcare Fund | 47.63K | 0.35% |
| iShares Trust-iShares Micro-Cap ETF | 46.95K | 0.34% |
| Simplify Exchange Traded Funds-Simplify Propel Opportunities ETF | 30.73K | 0.23% |
| American Century ETF Trust-Avantis U.S. Small Cap Equity ETF | 12.55K | 0.09% |
| SCHWAB CAPITAL TRUST-Schwab Total Stock Market Index Fund | 8.50K | 0.06% |
| Invesco Exch-Trd Fd. TRT II-Invesco NASDAQ Future Gen 200 ETF | 7.47K | 0.05% |
Frequently asked questions
Who is the largest shareholder of Immunic?
Aberdeen Group plc is the largest institutional shareholder of IMUX, owning 6.04% of shares outstanding (824.39K shares) as of its latest 13F filing.
What percentage of Immunic is owned by institutions?
Institutions own about 71.2% of IMUX shares and 71.9% of the public float.
How much of Immunic do insiders own?
Insiders, such as officers and directors, own about 0.97% of IMUX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.